title: Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.
abstract: Phosphoinositide (PI) 3-kinase is involved in insulin-mediated effects on glucose uptake, lipid deposition, and adiponectin secretion from adipocytes. Genetic disruption of the p85alpha regulatory subunit of PI 3-kinase increases insulin sensitivity, whereas elevated p85alpha levels are associated with insulin resistance through PI 3-kinase-dependent and -independent mechanisms. Adipose tissue plays a critical role in the antagonistic effects of growth hormone (GH) on insulin actions on carbohydrate and lipid metabolism through changes in gene transcription. The objective of this study was to assess the role of the p85alpha subunit of PI 3-kinase and PI 3-kinase signaling in GH-mediated insulin resistance in adipose tissue. To do this, p85alpha mRNA and protein expression and insulin receptor substrate (IRS)-1-associated PI 3-kinase activity were measured in white adipose tissue (WAT) of mice with GH excess, deficiency, and sufficiency. Additional studies using 3T3-F442A cells were conducted to confirm direct effects of GH on free p85alpha protein abundance. We found that p85alpha expression 1) is decreased in WAT from mice with isolated GH deficiency, 2) is increased in WAT from mice with chronic GH excess, 3) is acutely upregulated in WAT from GH-deficient and -sufficient mice after GH administration, and 4) is directly upregulated by GH in 3T3-F442A adipocytes. The insulin-induced increase in PI 3-kinase activity was robust in mice with GH deficiency, but not in mice with GH excess. In conclusion, GH regulates p85alpha expression and PI 3-kinase activity in WAT and provides a potential explanation for 1) the insulin hypersensitivity and associated obesity and hyperadiponectinemia of GH-deficient mice and 2) the insulin resistance and associated reduced fat mass and hypoadiponectinemia of mice with GH excess.
authors.affiliation: Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA. jd3v@virginia.edu
authors.forename: Juan-Pablo
authors.initials: JP
authors.lastname: del Rincon
authors.forename: Keiji
authors.initials: K
authors.lastname: Iida
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Gaylinn
authors.forename: Carrie E
authors.initials: CE
authors.lastname: McCurdy
authors.forename: J Wayne
authors.initials: JW
authors.lastname: Leitner
authors.forename: Linda A
authors.initials: LA
authors.lastname: Barbour
authors.forename: John J
authors.initials: JJ
authors.lastname: Kopchick
authors.forename: Jacob E
authors.initials: JE
authors.lastname: Friedman
authors.forename: Boris
authors.initials: B
authors.lastname: Draznin
authors.forename: Michael O
authors.initials: MO
authors.lastname: Thorner
mesh_terms: D016475:3T3 Cells; D017667:Adipocytes / Q000166:cytology* / Q000201:enzymology; D000273:Adipose Tissue / Q000201:enzymology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002417:Cattle; D017931:DNA Primers; D013006:Growth Hormone / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D007328:Insulin / Q000097:blood; D055504:Insulin Receptor Substrate Proteins; D007333:Insulin Resistance / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics* / Q000378:metabolism*; D010750:Phosphoproteins / Q000378:metabolism; D016133:Polymerase Chain Reaction
chemical_list: D001786:Blood Glucose; D017931:DNA Primers; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C526295:Irs1 protein, mouse; D010750:Phosphoproteins; D013006:Growth Hormone; D019869:Phosphatidylinositol 3-Kinases